These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 19369693

  • 1. Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
    Skalli S, Desruet MD, Bourre JC, Caravel JP, Vuillez JP.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2598-600. PubMed ID: 19369693
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J, Vizda J, Odrazka K.
    Urol Int; 2007 Aug; 78(1):50-7. PubMed ID: 17192733
    [Abstract] [Full Text] [Related]

  • 3. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN.
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
    Wang RF, Zhang CL, Zhu SL, Zhu M.
    Med Princ Pract; 2003 Mar; 12(2):97-101. PubMed ID: 12634464
    [Abstract] [Full Text] [Related]

  • 9. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS.
    J Clin Oncol; 2002 Jan 01; 20(1):189-96. PubMed ID: 11773169
    [Abstract] [Full Text] [Related]

  • 10. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P.
    Expert Opin Pharmacother; 2006 Aug 01; 7(11):1475-86. PubMed ID: 16859431
    [Abstract] [Full Text] [Related]

  • 11. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H, Luo S, Tan T, Mo T, Liang Z, Pu M, Jiao J, Zhong S, Wang Q, Hu Y.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec 01; 26(4):391-4. PubMed ID: 8732058
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.
    Dolezal J.
    Onkologie; 2009 Feb 01; 32(1-2):35-9. PubMed ID: 19209017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
    Sinzinger H, Weiss K, Hiltunen J.
    Anticancer Res; 2009 Aug 01; 29(8):3393-5. PubMed ID: 19661362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.